Ownership history in SILVERARC CAPITAL MANAGEMENT, LLC · 15 quarters on record
This page tracks every 13F SEC filing in which SILVERARC CAPITAL MANAGEMENT, LLC reported a position in ORIC PHARMACEUTICALS INC (ORIC). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | REDUCED | 1,116,604 | -832,204 | -42.7% | 1.27% | $9.1M | $8.18 |
| 2025 Q3 | ADDED | 1,948,808 | +147,979 | +8.2% | 3.15% | $23.4M | $12.00 |
| 2025 Q2 | REDUCED | 1,800,829 | -259,411 | -12.6% | 3.37% | $18.3M | $10.15 |
| 2025 Q1 | ADDED | 2,060,240 | +881,940 | +74.8% | 2.35% | $11.5M | $5.58 |
| 2024 Q4 | ADDED | 1,178,300 | +78,810 | +7.2% | 2.08% | $9.5M | $8.07 |
| 2024 Q3 | ADDED | 1,099,490 | +23,678 | +2.2% | 2.53% | $11.3M | $10.25 |
| 2024 Q2 | REDUCED | 1,075,812 | -37,195 | -3.3% | 1.79% | $7.6M | $7.07 |
| 2024 Q1 | REDUCED | 1,113,007 | -56,993 | -4.9% | 4.25% | $15.3M | $13.75 |
| 2023 Q4 | ADDED | 1,170,000 | +46,655 | +4.2% | 3.20% | $10.8M | $9.20 |
| 2023 Q3 | REDUCED | 1,123,345 | -327,477 | -22.6% | 2.06% | $6.8M | $6.05 |
As of 2025 Q4 — sorted by position size